Adhera Therapeutics, Inc. Proceeds from Short-term Debt
Adhera Therapeutics, Inc. reported Proceeds from Short-term Debt of $171.00 thousand for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-23.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromShortTermDebt · last filed 2021-08-23
- Adhera Therapeutics, Inc. proceeds from short-term debt for the quarter ending 2021-06-30 was $123.00K, a 132.08% increase year-over-year.
- Adhera Therapeutics, Inc. proceeds from short-term debt for the quarter ending 2021-03-31 was $48.00K, a 90.40% decline year-over-year.
- Adhera Therapeutics, Inc. proceeds from short-term debt for the quarter ending 2020-06-30 was $53.00K.
- Adhera Therapeutics, Inc. proceeds from short-term debt for the quarter ending 2020-03-31 was $500.00K.
| Period end | Proceeds from Short-term Debt 3 month | Proceeds from Short-term Debt 6 month |
|---|---|---|
| 2021-06-30 | $123.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-23 | $171.00K 10-Q · filed 2021-08-23 |
| 2021-03-31 | $48.00K 10-Q · filed 2021-05-24 | |
| 2020-06-30 | $53.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-23 | $553.00K 10-Q · filed 2021-08-23 |
| 2020-03-31 | $500.00K 10-Q · filed 2021-05-24 |